US Broker Ratings

Natera, Inc. (NTRA) Stock Analysis: Navigating Growth in the Molecular Testing Market

For investors seeking opportunities in the healthcare sector, Natera, Inc. (NTRA) presents a compelling case with its robust revenue growth and innovative molecular testing services. Based..

TG Therapeutics, Inc. (TGTX) Stock Analysis: A Biotech Powerhouse with a 29% Upside Potential

TG Therapeutics, Inc. (TGTX), a commercial-stage biopharmaceutical company, is capturing the attention of investors with its innovative approach to treating B-cell mediated diseases, particularly relapsing forms..

Insmed Incorporated (INSM) Stock Analysis: Exploring a 104.63% Upside Potential with Innovative Biotech Solutions

Insmed Incorporated (NASDAQ: INSM) stands out in the biotechnology sector with its robust pipeline of therapies aimed at treating serious and rare diseases. Headquartered in Bridgewater,..

Stevanato Group S.p.A. (STVN) Stock Analysis: Exploring a 29.47% Potential Upside

Stevanato Group S.p.A. (NYSE: STVN) is capturing investor attention with its promising 29.47% potential upside, according to the latest analyst ratings. This Italian healthcare company, with..

Tempus AI, Inc. (TEM) Stock Analysis: A Healthcare Innovator with 15.80% Potential Upside

Tempus AI, Inc. (NASDAQ: TEM), a healthcare technology leader, has emerged as a compelling investment opportunity within the health information services industry. Based in the United..

Oscar Health, Inc. (OSCR): Investor Outlook Shows Promising 14% Upside Potential

Oscar Health, Inc. (NYSE: OSCR), a notable player in the healthcare plans sector, has captured investors’ interest with its impressive growth metrics and compelling potential upside...

Sanofi (SNY) Stock Analysis: A Healthcare Giant with 32% Potential Upside

Sanofi (NASDAQ: SNY), a leading player in the healthcare sector, is making waves with a remarkable potential upside of 32.01%, according to analysts’ forecasts. With its..

Moderna, Inc. (MRNA) Stock Analysis: Understanding the Challenges and Opportunities in the Biotech Industry

Moderna, Inc. (NASDAQ: MRNA) remains a pivotal player in the biotechnology sector, with a market capitalization of $87.04 billion, reflecting its significant role in the healthcare..

Chemed Corp (CHE) Stock Analysis: A Healthcare Giant with 11.56% Upside Potential

Chemed Corp (NYSE: CHE), a prominent player in the healthcare sector, stands out for its steady performance and promising growth prospects. Operating primarily in the United..

Ascendis Pharma A/S (ASND) Stock Analysis: A Biotech Powerhouse with 35.87% Potential Upside

For investors seeking opportunities in the biotechnology sector, Ascendis Pharma A/S (NASDAQ: ASND) presents a compelling case. With a robust market capitalization of $14.82 billion, the..

Inspire Medical Systems, Inc. (INSP) Stock Analysis: Navigating Market Dynamics with an Eye on Growth

Inspire Medical Systems, Inc. (NYSE: INSP) stands at the forefront of the medical device industry, offering innovative solutions for patients with obstructive sleep apnea (OSA). Headquartered..

Humana Inc. (HUM) Investor Outlook: Analyzing a 12.58% Upside Potential and Robust Revenue Growth

As one of the prominent players in the healthcare sector, Humana Inc. (NYSE: HUM) stands out with its substantial market capitalization of $49.61 billion. Operating primarily..

Prestige Consumer Healthcare (PBH) Stock Analysis: A 35.82% Upside in the Healthcare Sector

Prestige Consumer Healthcare Inc. (NYSE: PBH) is capturing investor attention with its potential upside of 35.82%, making it a compelling candidate for those seeking opportunities in..

West Pharmaceutical Services, Inc. (WST) Stock Analysis: A Healthcare Giant with a 7.51% Upside Potential

West Pharmaceutical Services, Inc. (NYSE: WST) stands at the forefront of the healthcare sector, specializing in the design and manufacture of containment and delivery systems crucial..

Agilent Technologies, Inc. (A) Stock Analysis: Navigating Growth in Diagnostics with a 4.67% Upside

Agilent Technologies, Inc. (NYSE: A) stands as a formidable player in the healthcare sector, specifically within the diagnostics and research industry. With a market cap of..

Option Care Health, Inc. (OPCH) Stock Analysis: Stability in Healthcare with Strategic Growth Opportunities

Option Care Health, Inc. (NASDAQ: OPCH) has carved out a significant niche in the healthcare sector by specializing in home and alternate site infusion services within..

BioNTech SE (BNTX) Stock Analysis: Unraveling the 33% Upside Potential Amid Market Volatility

BioNTech SE (NASDAQ: BNTX), a prominent player in the biotechnology sector, is currently facing a mix of market challenges and opportunities that are intriguing for investors..

Teleflex Incorporated (TFX) Investor Outlook: Exploring the 18% Potential Upside

Teleflex Incorporated (NYSE: TFX), a prominent player in the healthcare sector specializing in medical instruments and supplies, has been capturing investor attention with its compelling growth..

Madrigal Pharmaceuticals, Inc. (MDGL) Stock Analysis: Exploring a 52% Potential Upside in the Biotech Sector

Investors with a keen eye on the biotechnology sector may find Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) an intriguing prospect, especially considering the company’s potential upside of..

The Cooper Companies, Inc. (COO) Investor Outlook: Exploring the 13.57% Potential Upside Amidst Healthcare Growth

The Cooper Companies, Inc. (NYSE: COO), a prominent player in the healthcare sector, operates at the intersection of vision care and women’s health. With a market..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds